期刊文献+

小鼠超声雾化吸入结核分枝杆菌噬菌体D29生物安全性的初步研究 被引量:3

Study on Biological Safety of Ultrasonic Atomized Inhalation of Mycobacteriophage D29 in Mice
下载PDF
导出
摘要 目的探讨小鼠超声雾化吸入结核分枝杆菌噬菌体D29的生物安全性,及噬菌体D29在小鼠肺组织中的活性变化规律,旨在为临床治疗肺结核提供一新途径。方法 8只小鼠分成两组,实验组4只超声雾化吸入分枝杆菌噬菌体D29,对照组4只超声雾化吸入空白培养基,观察不同时间肺的组织学改变,并检测不同时间肺组织冲洗液中噬菌体D29的活性。结果小鼠超声雾化吸入噬菌体D29后1、2、3、24h与对照组比较,肺组织结构正常,无任何炎症性改变,肺组织冲洗液中噬菌体D29活性1h后开始急剧下降,24h后无活性。结论小鼠超声雾化吸入噬菌体D29具有较高的生物安全性,噬菌体D29在小鼠肺内的存活具有高度时间依赖性。 To evaluate the biological safety of ultrasonic atomized inhalation of mycobacteriophage D29 in mice and the activity variation of mycobacteriophage D29 in mice lung tissue,to find a new way for clinic treatment of tuberculosis.Methods 8 mice were divided into two groups.The experimental group inhaled mycobacteriophage D29,and the control group inhaled Middlebrook 7H9 Medium.Histological changes of mice lung were observed after ultrasonic atomized inhalation of mycobacteriophage D29,and the activity of mycobacteriophage D29 was detected in the flushing fluid of mice lung tissue.Results The mice lung tissue was normal without any inflammatory changes compared with the controls at 1,2,3,24h after ultrasonic atomized inhalation of mycobacteriophage D29.The activity of mycobacteriophage D29 sharply declined after 1h of ultrasonic atomized inhalation of mycobacteriophage D29,and it was no activity after 24h.Conclusion Ultrasonic atomized inhalation of mycobacteriophage D29 in mice has highly biological safety,and the activity of mycobacteriophage D29 in the mice lung is highly time-dependent.
出处 《医学综述》 2010年第15期2397-2399,共3页 Medical Recapitulate
关键词 结核分枝杆菌噬菌体D29 超声雾化吸入 生物安全性 Mycobacteriophage D29 Ultrasonic Atomized Inhalation Biological Safety
  • 相关文献

参考文献10

  • 1全国结核病流行病学抽样调查技术指导组.2000年全国结核病流行病学抽样调查报告[J].中国防痨杂志,2002,24(2):65-108. 被引量:1376
  • 2Ford ME,Sarkis GJ,Belanger AE,et al.Genome structure of mycobacteriopha D29:implications for phage evolution[J].J Mol Biol,1998,279(1):143-164.
  • 3黄海荣,马玙.噬菌体在结核分支杆菌研究中的应用[J].中华结核和呼吸杂志,2002,25(8):497-499. 被引量:13
  • 4Platt R,Reynolds DL,Phillips GJ.Development of a novel method of lytic phage delivery by use of a bacteriophage p22 site-specific recombination system[J].FEMS Microbiol Lett,2003,223(2):259-265.
  • 5Weber-Dabrowska B,Mulczyk M,Górski A.Bacteriophage therapy for infections in cancer patients[J].Clin Appl Immunol Rev,2001,1(3):131-134.
  • 6Bretscher MT,Althaus CL,Müller V,et al.Recombination in HIV and the evolution of drug resistance:for better or for worse[J].Bioessays,2004,26(2):180-188.
  • 7Broxmeyer L,Sosnowska D,Miltner E,et al.Killing of mycobacterium avium and mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium:A model for phage therapy of intracellular bacterial pathogens[J].J Infect Dis,2002,186(8):1155-1160.
  • 8Muzaffar R,Batool S,Aziz F,et al.Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens[J].Int J Tuberc Lung Dis,2002,6(7):635-640.
  • 9Albert H,Trollip A,Seaman T,et al.Simple,phage-based(FASTPlaque)technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum[J].Int J Tuberc Lung Dis,2004,8(9):1114-1119.
  • 10Sulakvelidze A,Alavidze Z,Morris JG Jr.Bacteriophage therapy[J].Antimicrob Agents Chemother,2001,45(3):649-659.

二级参考文献7

共引文献1387

同被引文献53

  • 1谢尔凡,杨宗城.气道上皮细胞与炎症介质[J].中国实验临床免疫学杂志,1995,7(4):47-48. 被引量:1
  • 2刘岽,唐亮,周彩存,谈立松.VGFR噬菌体疫苗的构建及抗肿瘤效果[J].实用医药杂志,2006,23(5):586-589. 被引量:3
  • 3陈慰峰.医学免疫学[M].4版.北京:人民卫生出版社出版,2005:263.
  • 4Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface[J]. Science, 1985,228 (4705): 1315-1317.
  • 5Weber-Dabrowska B, Mulczyk M, Gorski A. Bacteriophage therapy for infections in cancer patients[J]. Clin Appl lnununol Rev, 2001,1(3-4):131-134.
  • 6Wright A, Hawkins CH, Anggiird EE, et ol. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aerugirwsa; a preliminary report of efficacy[J)' Clin Otolaryngol, 2009, 34 (4): 349-357.
  • 7Platt R,Reynolds DL, Phillips GJ. Development of a novel method of lytic phage delivery by use of a bacteriophage P22 site-specific recombination system[J]. FEMS Microbiol Lett, 2003,223(2): 259-265.
  • 8ClarkJR, MarchJB. Bacteriophages and biotechnology:vaccines, gene therapy and antibacterials[J]. Trends Biotechnol, 2006, 24 (5): 212-218.
  • 9Aronow R, Danon D, Shahar A, et al, Electron microscopy of in vitro endocytosis of T2 phage by cells from rabbit peritoneal exudates[J).J Exp Med, 1964, 120 (5): 943-954.
  • 10Ishiura M, Hirose S, Uchida T, et ol. Phage particle-mediated gene transfer to cultured mammalian cells[J). Mol Cell Bioi, 1982,2(6): 607-616.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部